IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-01482654.html
   My bibliography  Save this paper

Differential effects of childhood trauma and cannabis use disorders in ă patients suffering from schizophrenia

Author

Listed:
  • G. Baudin
  • O. Godin
  • M. Lajnef
  • Bruno Aouizerate
  • F. Berna
  • L. Brunel
  • D. Capdevielle
  • I. Chereau
  • J. M. Dorey
  • C. Dubertret
  • J. Dubreucq
  • C. Faget
  • G. Fond
  • F. Gabayet
  • H. Laouamri
  • C. Lançon

    (Departement de Psychiatrie - LA CONCEPTION - Hôpital de la Conception [CHU - APHM], SPMC - Santé Publique et maladies Chroniques : Qualité de vie Concepts, Usages et Limites, Déterminants - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille)

  • Y. Le Strat
  • A. M. Tronche
  • D. Misdrahi
  • R. Rey
  • C. Passerieux
  • A. Schandrin
  • M. Urbach
  • P. Vidalhet
  • P. M. Llorca
  • F. Schurhoff
  • Fondamental Acad Ctr Expertise

Abstract

Background: Childhood trauma (CT) and cannabis use are both ă environmental and modifier risk factors for schizophrenia. However, ă little is known about how they interact in schizophrenia. We examined ă the main effect of each of these two environmental factors on the ă clinical expression of the disease using a large set of variables, and ă we tested whether and how cannabis and CT interact to influence the ă course and the presentation of the illness. ă Methods: A sample of 366 patients who met the DSM-IV-TR criteria for ă schizophrenia was recruited through the FACE-SCZ (Fondamental Advanced ă Centre of Expertise - Schizophrenia) network. Patients completed a large ă standardized clinical evaluation including Structured Clinical Interview ă for DSM Disorders-I (SCID-I), Positive and Negative Symptoms Scale ă (PANSS), Columbia-Suicide Severity Rating Scale (C-SSRS), Global ă Assessment of Functioning (GAF), Short-Quality of Life-18 (S-QoL-18), ă and Medication Adherence Rating Scale (MARS). We assessed CT with the ă Childhood Trauma Questionnaire and cannabis status with SCID-I. ă Results: CT significantly predicted the number of hospitalizations, GAF, ă and S-QoL-18 scores, as well as the PANSS total, positive, excitement, ă and emotional distress scores. Cannabis use disorders significantly ă predicted age of onset, and MARS. There was no significant interaction ă between CT and cannabis use disorders. However, we found evidence of a ă correlation between these two risk factors. ă Conclusions: CT and cannabis both have differential deleterious effects ă on clinical and functional outcomes in patients with schizophrenia. Our ă results highlight the need to systematically assess the presence of ă these risk factors and adopt suitable therapeutic interventions. (C) ă 2016 Elsevier B.V. All rights reserved.

Suggested Citation

  • G. Baudin & O. Godin & M. Lajnef & Bruno Aouizerate & F. Berna & L. Brunel & D. Capdevielle & I. Chereau & J. M. Dorey & C. Dubertret & J. Dubreucq & C. Faget & G. Fond & F. Gabayet & H. Laouamri & C., 2016. "Differential effects of childhood trauma and cannabis use disorders in ă patients suffering from schizophrenia," Post-Print hal-01482654, HAL.
  • Handle: RePEc:hal:journl:hal-01482654
    DOI: 10.1016/j.schres.2016.04.042
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Cem İngeç & Esin Evren Kılıçaslan, 2020. "The effect of childhood trauma on age of onset in patients with schizophrenia," International Journal of Social Psychiatry, , vol. 66(8), pages 763-769, December.
    2. Valerio Ricci & Giovanni Martinotti & Domenico De Berardis & Giuseppe Maina, 2022. "Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report," IJERPH, MDPI, vol. 19(23), pages 1-9, November.

    More about this item

    Keywords

    Quality of Life;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-01482654. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.